Kraig Biocraft Laboratories (KBLB) Depreciation & Amortization (CF) (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $7602.0 for Q4 2025.

• Depreciation & Amortization (CF) for Q4 2025 came in at $7602.0, up 25.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $25114.0 (down 4.0% YoY), and the FY2025 annual result was $25113.0, down 4.0% from the prior year.
• Depreciation & Amortization (CF) came in at $7602.0 for Q4 2025 at Kraig Biocraft Laboratories, up from $5992.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $7602.0 in Q4 2025 to a low of $5683.0 in Q1 2025.
• The 5-year median for Depreciation & Amortization (CF) is $6692.0 (2021), against an average of $6656.6.
• Across the five-year window, Depreciation & Amortization (CF) fell 28.2% in 2021 and climbed 25.61% in 2025, its largest moves.
• Kraig Biocraft Laboratories' Depreciation & Amortization (CF) stood at $6833.0 in 2021, then fell by 2.44% to $6666.0 in 2022, then advanced by 13.68% to $7578.0 in 2023, then slipped by 20.14% to $6052.0 in 2024, then gained by 25.61% to $7602.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $7602.0 (Q4 2025), $5992.0 (Q3 2025), and $5837.0 (Q2 2025), per Business Quant data.